Chimeric compounds targeting proteins, compositions, methods, and uses thereof
AssigneeBioTheryX, Inc.
InventorsKyle W. H. Chan, Leah Fung, Robert Sullivan, Paul E. Erdman, Frank Mercurio, Eduardo Torres
Life of this patent
Estimating the term…
Loading patent…
AssigneeBioTheryX, Inc.
InventorsKyle W. H. Chan, Leah Fung, Robert Sullivan, Paul E. Erdman, Frank Mercurio, Eduardo Torres
Estimating the term…
The present invention provides chimeric compounds that modulate protein function, to restore protein homeostasis, including cytokine, aiolos, and/or ikaros activity, TNF-alpha activity, CK1-alpha activity and cell-cell adhesion. The invention provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of protein-mediated diseases, disorders, and conditions, such as cytokine-mediated diseases, disorders, and conditions, including inflammation, fibromyalgia, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, inflammatory bowel diseases, Crohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, Alzheimer's disease, organ transplant rejection, and cancer, are provided.
A compound of Formula (I):
A compound of Formula (II):
Dependencies are inferred from the claim text.